Introduction

OM Pharma SA occupies a key position in today's pharmaceutical industry. The company's atypical and lasting independence is largely responsible for this performance.

Today, OM Pharma SA is a recognized authority in two product lines and research fields: synthetic (e.g. Doxium, Dicynone) and biotechnology products (e.g. Broncho-Vaxom, Uro-Vaxom). In view of its considerable expertise in the area, new product research is now concentrated on applied immunology. These products find wide application in the treatment of bronchitis, respiratory infection, diabetic retinopathy, capillary haemorhages, chronic obstructive pulmonary diseases.

New state of the art biotech production centre

OM Pharma Group

	OM Pharma SA Switzerland, Portugal, Peru
ETREA SA Switzerland	LAB SSSV SA Switzerland	S-OM SA Switzerland